相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A macrophage-hepatocyte glucocorticoid receptor axis coordinates fasting ketogenesis
Anne Loft et al.
CELL METABOLISM (2022)
Type 1 diabetes, cognitive ability and incidence of cardiovascular disease and death over 60 years of follow-up time in men
Elin Dybjer et al.
DIABETIC MEDICINE (2022)
Diabetic ketoacidosis in pregnancy - Case series, pathophysiology, and review of the literature
Tamar Eshkoli et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2022)
The SGLT2 inhibitor dapagliflozin promotes systemic FFA mobilization, enhances hepatic β-oxidation and increases ketosis
Kristina Wallenius et al.
JOURNAL OF LIPID RESEARCH (2022)
SGLT2 inhibitors break the vicious circle between heart failure and insulin resistance: targeting energy metabolism
Xiaodan Wang et al.
HEART FAILURE REVIEWS (2022)
The SGLT2 Inhibitor Dapagliflozin Increases the Oxidation of Ingested Fatty Acids to Ketones in Type 2 Diabetes
Roselle A. Herring et al.
DIABETES CARE (2022)
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Water and Sodium Metabolism
Jun Tang et al.
FRONTIERS IN PHARMACOLOGY (2022)
SGLT2 inhibitor and loop diuretic induce different vasopressin and fluid homeostatic responses in nondiabetic rats
Takahiro Masuda et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2022)
Metabolomics study reveals the alteration of fatty acid oxidation in the hearts of diabetic mice by empagliflozin
Yingwei Zhang et al.
MOLECULAR OMICS (2022)
Changing epidemiology of chronic kidney disease as a result of type 2 diabetes mellitus from 1990 to 2017: Estimates from Global Burden of Disease 2017
Huixian Li et al.
JOURNAL OF DIABETES INVESTIGATION (2021)
Metabolic and Signaling Roles of Ketone Bodies in Health and Disease
Patrycja Puchalska et al.
Annual Review of Nutrition (2021)
Gluconeogenesis, But Not Glycogenolysis, Contributes to the Increase in Endogenous Glucose Production by SGLT-2 Inhibition
Peter Wolf et al.
DIABETES CARE (2021)
Crosstalk between Sodium-Glucose Cotransporter Inhibitors and Sodium-Hydrogen Exchanger 1 and 3 in Cardiometabolic Diseases
Al-Anood Al-Shamasi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Euglycemic Ketoacidosis as a Complication of SGLT2 Inhibitor Therapy
Biff F. Palmer et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)
Identifying Risk Factors for Diabetic Ketoacidosis Associated with SGLT2 Inhibitors: a Nationwide Cohort Study in the USA
Michael Fralick et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2021)
The Effects of SGLT2 Inhibitors on Lipid Metabolism
Zsolt Szekeres et al.
METABOLITES (2021)
The Na/K-ATPase Signaling and SGLT2 Inhibitor-Mediated Cardiorenal Protection: A Crossed Road?
Jiang Liu et al.
JOURNAL OF MEMBRANE BIOLOGY (2021)
The Role of Very Low Calorie Ketogenic Diet in Sympathetic Activation through Cortisol Secretion in Male Obese Population
Rita Polito et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on atherosclerosis: from pharmacology to pre-clinical and clinical therapeutics
Zhenghong Liu et al.
THERANOSTICS (2021)
Growth hormone directly favors hepatic ketogenesis in persons with prediabetes or type 2 diabetes mellitus treated with empagliflozin
Aline Franco da Rocha et al.
ENDOCRINE (2021)
A Review on the Effects of New Anti-Diabetic Drugs on Platelet Function
Habib Yaribeygi et al.
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2020)
Effect of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on gluconeogenesis in proximal renal tubules
Jin Hee Kim et al.
DIABETES OBESITY & METABOLISM (2020)
Molecular mechanisms by which SGLT2 inhibitors can induce insulin sensitivity in diabetic milieu: A mechanistic review
Habib Yaribeygi et al.
LIFE SCIENCES (2020)
Neuromodulatory effects of anti-diabetes medications: A mechanistic review
Habib Yaribeygi et al.
PHARMACOLOGICAL RESEARCH (2020)
Trends in Incidence of Type 1 and Type 2 Diabetes Among Youths — Selected Counties and Indian Reservations, United States, 2002–2015
Jasmin Divers et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Glucocorticoid-Induced Fatty Liver Disease
Leili Rahimi et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2020)
Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis A Multicenter Cohort Study
Antonios Douros et al.
ANNALS OF INTERNAL MEDICINE (2020)
Tubular effects of sodium-glucose cotransporter 2 inhibitors: intended and unintended consequences
Jessica A. Dominguez Rieg et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2020)
SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition
Issei Tomita et al.
CELL METABOLISM (2020)
A role for tubular Na+/H+ exchanger NHE3 in the natriuretic effect of the SGLT2 inhibitor empagliflozin
Akira Onishi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2020)
EMPAGLIFLOZIN IS MORE EFFECTIVE IN REDUCING MICROALBUMINURIA AND ALT LEVELS COMPARED WITH DAPAGLIFLOZIN: REAL LIFE EXPERIENCE
H. G. Gunhan et al.
ACTA ENDOCRINOLOGICA-BUCHAREST (2020)
Osmotic diuresis by SGLT2 inhibition stimulates vasopressin-induced water reabsorption to maintain body fluid volume
Takahiro Masuda et al.
PHYSIOLOGICAL REPORTS (2020)
Effects of antidiabetic drugs on NLRP3 inflammasome activity, with a focus on diabetic kidneys
Habib Yaribeygi et al.
DRUG DISCOVERY TODAY (2019)
Sodium-glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways
Habib Yaribeygi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
A review of the molecular mechanisms of hyperglycemia-induced free radical generation leading to oxidative stress
Habib Yaribeygi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Euglycemic diabetic ketoacidosis
Leonid Barski et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2019)
Ketone Body Signaling Mediates Intestinal Stem Cell Homeostasis and Adaptation to Diet
Chia-Wei Cheng et al.
CELL (2019)
Sodium-glucose cotransporter 2 inhibitors regulate ketone body metabolism via inter-organ crosstalk
Jin Hee Kim et al.
DIABETES OBESITY & METABOLISM (2019)
Sodium-glucose cotransporter inhibitors and oxidative stress: An update
Habib Yaribeygi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box!
Golnaz Ranjbar et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Effects of newly introduced antidiabetic drugs on autophagy
Milad Ashrafizadeh et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2019)
Hepatic Gluconeogenic Response to Single and Long-Term SGLT2 Inhibition in Lean/Obese Male Hepatic G6pc-Reporter Mice
Yuka Inaba et al.
ENDOCRINOLOGY (2019)
Dapagliflozin Aggravates Renal Injury via Promoting Gluconeogenesis in db/db Mice
Yingli Jia et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Ketone bodies as epigenetic modifiers
Hai-Bin Ruan et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2018)
Endogenous Glucose Production and Hormonal Changes in Response to Canagliflozin and Liraglutide Combination Therapy
Robert Martinez et al.
DIABETES (2018)
Trends in Diabetic Ketoacidosis Hospitalizations and In-Hospital Mortality - United States, 2000-2014
Stephen R. Benoit et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)
Molecular pathways associated with oxidative stress in diabetes mellitus
Osasenaga Macdonald Ighodaro
BIOMEDICINE & PHARMACOTHERAPY (2018)
MECHANISMS OF INSULIN ACTION AND INSULIN RESISTANCE
Max C. Petersen et al.
PHYSIOLOGICAL REVIEWS (2018)
Risk of Diabetic Ketoacidosis after Initiation of an SGLT2 Inhibitor
Michael Fralick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Guidelines for management of diabetic ketoacidosis: time to revise?
Ketan K. Dhatariya et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Beta-adrenergic receptors are critical for weight loss but not for other metabolic adaptations to the consumption of a ketogenic diet in male mice
Nicholas Douris et al.
MOLECULAR METABOLISM (2017)
Euglycemic Diabetic Ketoacidosis: A Review
Anar Modi et al.
CURRENT DIABETES REVIEWS (2017)
Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data
Jenny E. Blau et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2017)
Activation and Inhibition of Sodium-Hydrogen Exchanger Is a Mechanism That Links the Pathophysiology and Treatment of Diabetes Mellitus With That of Heart Failure
Milton Packer
CIRCULATION (2017)
Ketosis and diabetic ketoacidosis in response to SGLT2 inhibitors: Basic mechanisms and therapeutic perspectives
Hongyu Qiu et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2017)
Renal Handling of Ketones in Response to Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 2 Diabetes
Ele Ferrannini et al.
DIABETES CARE (2017)
The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse Model
Michael Joubert et al.
DIABETES (2017)
Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics
Patrycja Puchalska et al.
CELL METABOLISM (2017)
Novel developments in differentiating the role of renal and intestinal sodium hydrogen exchanger 3
Jessica A. Dominguez Rieg et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2016)
Shift to Fatty Substrate Utilization in Response to Sodium-Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes
Ele Ferrannini et al.
DIABETES (2016)
Effects of diuretics on sodium-dependent glucose cotransporter 2 inhibitor-induced changes in blood pressure in obese rats suffering from the metabolic syndrome
Asadur Rahman et al.
JOURNAL OF HYPERTENSION (2016)
The SGLT2 inhibitor empagliflozin improves insulin sensitivity in db/db mice both as monotherapy and in combination with linagliptin
Matthias Kern et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
SGLT2 inhibitors in the management of type 2 diabetes
R. P. Monica Reddy et al.
ENDOCRINE (2016)
Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors
Julio Rosenstock et al.
DIABETES CARE (2015)
SGLT2 Inhibitors May Predispose to Ketoacidosis
Simeon I. Taylor et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion
Caroline Bonner et al.
NATURE MEDICINE (2015)
Diagnosis and Classification of Diabetes Mellitus
DIABETES CARE (2014)
Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years
J. P. H. Wilding et al.
DIABETES OBESITY & METABOLISM (2014)
Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production
Aurora Merovci et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients
Ele Ferrannini et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Functional Role of Glucose Metabolism, Osmotic Stress, and Sodium-Glucose Cotransporter Isoform-Mediated Transport on Na+/H+ Exchanger Isoform 3 Activity in the Renal Proximal Tubule
Thaissa Dantas Pessoa et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Sodium Glucose Co-Transporter 2 Inhibitors and Their Mechanism for Improving Glycemia in Patients With Type 2 Diabetes
Jaime A. Davidson et al.
POSTGRADUATE MEDICINE (2014)
Ketone bodies as signaling metabolites
John C. Newman et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice
Volker Vallon et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2014)
Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia
Timo Rieg et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2014)
Proximal tubule specific knockout of the Na+/H+ exchanger NHE3: effects on bicarbonate absorption and ammonium excretion
Hong C. Li et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Diabetic Ketoacidosis A Silent Death
Zabiullah Ali et al.
AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY (2012)
Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes
Christine Clar et al.
BMJ OPEN (2012)
Gluconeogenesis Defect Presenting With Resistant Hyperglycemia and Acidosis Mimicking Diabetic Ketoacidosis
Muhammet Sukru Paksu et al.
PEDIATRIC EMERGENCY CARE (2011)
Mechanisms of proximal tubule sodium transport regulation that link extracellular fluid volume and blood pressure
Alicia A. McDonough
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2010)
SGLT2 inhibition - a novel strategy for diabetes treatment
Edward C. Chao et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Diabetic ketoacidosis in children and adolescents with diabetes
Joseph Wolfsdorf et al.
PEDIATRIC DIABETES (2009)
Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats
Songping Han et al.
DIABETES (2008)
Pathophysiology of ketoacidosis in Type 2 diabetes mellitus
P Linfoot et al.
DIABETIC MEDICINE (2005)
Glucagon and regulation of glucose metabolism
GQ Jiang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
分享论文
